Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A0A3S5H6E9
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005524 | ATP binding | 5 | 2 |
GO:0017076 | purine nucleotide binding | 4 | 2 |
GO:0030554 | adenyl nucleotide binding | 5 | 2 |
GO:0032553 | ribonucleotide binding | 3 | 2 |
GO:0032555 | purine ribonucleotide binding | 4 | 2 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 2 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 2 |
GO:0036094 | small molecule binding | 2 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043168 | anion binding | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0097367 | carbohydrate derivative binding | 2 | 2 |
GO:1901265 | nucleoside phosphate binding | 3 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.504 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.311 |
CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.408 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.199 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.385 |
DEG_APCC_DBOX_1 | 65 | 73 | PF00400 | 0.384 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.362 |
DOC_MAPK_gen_1 | 63 | 72 | PF00069 | 0.390 |
DOC_MAPK_MEF2A_6 | 63 | 72 | PF00069 | 0.390 |
DOC_PP1_RVXF_1 | 113 | 120 | PF00149 | 0.199 |
DOC_PP4_MxPP_1 | 153 | 156 | PF00568 | 0.515 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.199 |
LIG_14-3-3_CanoR_1 | 141 | 148 | PF00244 | 0.440 |
LIG_Actin_WH2_2 | 126 | 143 | PF00022 | 0.199 |
LIG_BRCT_BRCA1_1 | 72 | 76 | PF00533 | 0.199 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.423 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.199 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.199 |
LIG_FHA_2 | 25 | 31 | PF00498 | 0.334 |
LIG_LIR_Apic_2 | 146 | 151 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 3 | 12 | PF02991 | 0.301 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.199 |
LIG_LIR_Nem_3 | 3 | 8 | PF02991 | 0.313 |
LIG_SH2_CRK | 5 | 9 | PF00017 | 0.300 |
LIG_SH2_STAT3 | 100 | 103 | PF00017 | 0.199 |
LIG_SUMO_SIM_par_1 | 23 | 30 | PF11976 | 0.329 |
LIG_SUMO_SIM_par_1 | 66 | 71 | PF11976 | 0.385 |
LIG_UBA3_1 | 25 | 32 | PF00899 | 0.343 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.199 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.330 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.415 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.442 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.328 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.199 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.199 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.422 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.417 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.424 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.408 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.301 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.423 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.302 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.330 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.199 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.308 |
TRG_ER_diArg_1 | 148 | 150 | PF00400 | 0.497 |
TRG_ER_diArg_1 | 151 | 154 | PF00400 | 0.512 |
TRG_ER_diArg_1 | 63 | 66 | PF00400 | 0.410 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.199 |